View in EDS

Impact of Desloratadine on Treatment Response and Inflammation During Neoadjuvant Chemotherapy in Stage II-III Breast Cancer: A Randomized Pilot Study.

Saved in:

Bibliographic Details
Title:	Impact of Desloratadine on Treatment Response and Inflammation During Neoadjuvant Chemotherapy in Stage II-III Breast Cancer: A Randomized Pilot Study.
Authors:	Azimi H; Department of Immunology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran., Jafari A; Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Khandozi SR; Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Bagheri Y; Clinical Research Development Unit (CRDU), Agh-ghala Hospital, Golestan University of Medical Science, Gorgan, Iran., Saghaeian Jazi M; Metabolic Disorders Research Center, Biomedical Research Institute, Golestan University of Medical Sciences, Gorgan, Iran., Ghorbani S; Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Roshandel G; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran., Davoodi H; Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Electronic address: homdavoodi@yahoo.com.
Source:	Archives of medical research [Arch Med Res] 2026 Jun; Vol. 57 (4), pp. 103333. Date of Electronic Publication: 2025 Nov 11.
Publication Type:	Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II
Journal Info:	Publisher: Elsevier Science Country of Publication: United States NLM ID: 9312706 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5487 (Electronic) Linking ISSN: 01884409 NLM ISO Abbreviation: Arch Med Res Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1873-5487
DOI:	10.1016/j.arcmed.2025.103333